MicroPort Endovascular MedTech Ltd - Asset Resilience Ratio

Latest as of June 2026: 18.30%

MicroPort Endovascular MedTech Ltd (688016) has an Asset Resilience Ratio of 18.30% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See MicroPort Endovascular MedTech Ltd (688016) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥906.83 Million
≈ $132.70 Million USD Cash + Short-term Investments

Total Assets

CN¥4.96 Billion
≈ $725.32 Million USD All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2025–2025)

This chart shows how MicroPort Endovascular MedTech Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see MicroPort Endovascular MedTech Ltd (688016) total assets.

Liquid Assets Composition Over Time

This chart breaks down MicroPort Endovascular MedTech Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 688016 liabilities breakdown for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥906.83 Million 18.3%
Total Liquid Assets CN¥906.83 Million 18.30%

Asset Resilience Insights

  • Good Liquidity Position: MicroPort Endovascular MedTech Ltd maintains a healthy 18.30% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

MicroPort Endovascular MedTech Ltd Industry Peers by Asset Resilience Ratio

Compare MicroPort Endovascular MedTech Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Medtronic plc
SA:MDTC34
Medical Devices 7.82%
Demant A/S
CO:DEMANT
Medical Devices -2.59%
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Medartis Holding AG
SW:MED
Medical Devices 0.00%
Xiangyu Medical Co. Ltd. A
SHG:688626
Medical Devices 1.53%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
Medical Devices 25.01%
Mediantechn
PA:ALMDT
Medical Devices 0.45%

Annual Asset Resilience Ratio for MicroPort Endovascular MedTech Ltd (2025–2025)

The table below shows the annual Asset Resilience Ratio data for MicroPort Endovascular MedTech Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 2.16% CN¥100.37 Million
≈ $14.69 Million
CN¥4.64 Billion
≈ $679.15 Million
--
pp = percentage points

About MicroPort Endovascular MedTech Ltd

SHG:688016 China Medical Devices
Market Cap
$1.53 Billion
CN¥10.45 Billion CNY
Market Cap Rank
#7209 Global
#1548 in China
Share Price
CN¥84.76
Change (1 day)
+0.72%
52-Week Range
CN¥83.14 - CN¥112.72
All Time High
CN¥443.37
About

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft syste… Read more